Resected specimens from cancer patients were used in the analysis of the p53 mutations in the previous studies (Yang, 1980; Yang and Qiu, 1987; Qiu and Yang, 1988; Wang et al, 1990; Shi et al, 1999; Mandard et al, 2000). This evidence concerns the gene TP53 and cancer.